EuBiologics Co., Ltd. (KOSDAQ: 206650)
10,360
+390 (3.91%)
Sep 11, 2024, 11:08 AM KST
EuBiologics Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 9,897 | 9,897 | 11,044 | 6,535 | 53,088 |
Short-Term Investments | 1,594 | 1,594 | 180 | 25,139 | 1,786 |
Cash & Short-Term Investments | 11,491 | 11,491 | 11,224 | 31,673 | 54,874 |
Cash Growth | 2.38% | 2.38% | -64.56% | -42.28% | - |
Accounts Receivable | 5,890 | 5,890 | 3,190 | 2,569 | 2,657 |
Other Receivables | 2,526 | 2,526 | 41.71 | 147.08 | 612.9 |
Receivables | 8,628 | 8,628 | 3,524 | 3,007 | 4,354 |
Inventory | 13,342 | 13,342 | 18,013 | 14,776 | 9,252 |
Prepaid Expenses | 1,065 | 1,065 | 1,210 | 1,052 | 701.04 |
Other Current Assets | 7,238 | 7,238 | 7,168 | 3,211 | 2,225 |
Total Current Assets | 41,764 | 41,764 | 41,139 | 53,720 | 71,407 |
Property, Plant & Equipment | 70,096 | 70,096 | 72,815 | 70,046 | 68,538 |
Long-Term Investments | 15,410 | 15,410 | 17,399 | 13,163 | 8,632 |
Goodwill | 888.92 | 888.92 | 888.92 | 888.92 | 888.92 |
Other Intangible Assets | 2,593 | 2,593 | 1,650 | 851.31 | 637.97 |
Long-Term Deferred Tax Assets | 5,538 | 5,538 | 5,273 | 5,372 | 2,577 |
Long-Term Deferred Charges | 14,089 | 14,089 | 21,686 | 4,033 | 2,394 |
Other Long-Term Assets | 1,313 | 1,313 | 861.6 | 1,922 | 258.97 |
Total Assets | 151,806 | 151,806 | 162,066 | 150,438 | 155,955 |
Accounts Payable | 635.71 | 635.71 | 856.17 | 308.15 | 198.96 |
Accrued Expenses | 1,293 | 1,293 | 3,885 | 2,640 | 2,615 |
Short-Term Debt | 8,656 | 8,656 | 8,500 | 2,500 | 4,500 |
Current Portion of Long-Term Debt | 800 | 800 | 400 | 6,000 | - |
Current Portion of Leases | 976.59 | 976.59 | 1,033 | 801.87 | 698.07 |
Current Income Taxes Payable | 998.09 | 998.09 | - | - | - |
Other Current Liabilities | 12,339 | 12,339 | 9,950 | 5,032 | 27,185 |
Total Current Liabilities | 25,699 | 25,699 | 24,624 | 17,282 | 35,197 |
Long-Term Debt | 2,800 | 2,800 | 3,600 | 4,000 | 14,965 |
Long-Term Leases | 1,546 | 1,546 | 2,129 | 2,219 | 2,408 |
Other Long-Term Liabilities | 16,148 | 16,148 | 11,760 | 9,673 | 6,509 |
Total Liabilities | 46,988 | 46,988 | 42,631 | 33,175 | 59,079 |
Common Stock | 18,227 | 18,227 | 18,222 | 18,137 | 17,433 |
Additional Paid-In Capital | 223,103 | 223,103 | 220,859 | 219,542 | 171,522 |
Retained Earnings | -135,103 | -135,103 | -121,224 | -120,125 | -92,551 |
Comprensive Income & Other | 5,145 | 5,145 | 6,652 | 2,445 | 472.1 |
Total Common Equity | 111,373 | 111,373 | 124,510 | 119,999 | 96,877 |
Minority Interest | -6,555 | -6,555 | -5,075 | -2,736 | - |
Shareholders' Equity | 104,818 | 104,818 | 119,435 | 117,263 | 96,877 |
Total Liabilities & Equity | 151,806 | 151,806 | 162,066 | 150,438 | 155,955 |
Total Debt | 14,779 | 14,779 | 15,663 | 15,521 | 22,571 |
Net Cash (Debt) | -3,287 | -3,287 | -4,439 | 16,152 | 32,303 |
Net Cash Growth | - | - | - | -50.00% | - |
Net Cash Per Share | -90.19 | -90.19 | -121.93 | 455.63 | 1152.93 |
Filing Date Shares Outstanding | 36.45 | 36.45 | 36.44 | 36.27 | 34.87 |
Total Common Shares Outstanding | 36.45 | 36.45 | 36.44 | 36.27 | 34.87 |
Working Capital | 16,065 | 16,065 | 16,514 | 36,438 | 36,210 |
Book Value Per Share | 3055.10 | 3055.10 | 3416.39 | 3308.10 | 2778.58 |
Tangible Book Value | 107,891 | 107,891 | 121,971 | 118,259 | 95,350 |
Tangible Book Value Per Share | 2959.59 | 2959.59 | 3346.72 | 3260.12 | 2734.79 |
Land | 5,435 | 5,435 | 5,435 | 5,435 | 5,435 |
Buildings | 30,819 | 30,819 | 30,642 | 31,867 | 31,727 |
Machinery | 47,586 | 47,586 | 41,374 | 36,630 | 32,484 |
Construction In Progress | 11,642 | 11,642 | 14,444 | 9,376 | 6,711 |
Source: S&P Capital IQ. Standard template. Financial Sources.